Navigation Links
Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results
Date:11/4/2008

HOUSTON, Nov. 4 /PRNewswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: CYBX) today announced that the company will report financial results for the second quarter ended October 24, 2008 of its fiscal year ending April 24, 2009 on Wednesday, November 19, 2008 at 5:00 PM EST. The company will conduct a conference call to discuss those results on Thursday, November 20, 2008 at 9:00 AM EST.

Fiscal Year 2009 Second Quarter Results Conference Call Instructions

To listen to the conference call live by telephone dial 877-313-8035 (if dialing from within the U.S.) or 706-679-4838 (if dialing from outside the U.S.). The conference ID is 71901126; the leader is Dan Moore. Presentation slides will be available on-line at http://www.cyberonics.com no later than 8:00 AM EST on Thursday, November 20, 2008. A replay of the conference call will be available approximately two hours after the completion of the live call by dialing 800-642-1687 (if dialing from within the U.S.) or 706-645-9291 (if dialing outside the U.S.). The replay conference ID access code is 71901126. The replay will be available for one week on the above number, and subsequently on the Company's website for a period of six months.

About Cyberonics, Inc. and VNS TherapyTM

Cyberonics, Inc. (Nasdaq: CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy(TM) System, which is FDA-approved for the treatments of epilepsy and depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

Additional information on Cyberonics and VNS Therapy is available at http://www.cyberonics.com and http://www.vnstherapy.com.

CONTACT INFORMATION:

Greg Browne, CFO

Cyberonics, Inc.

100 Cyberonics Blvd., Houston, TX 77058

Main: (281) 228-7262/Fax: (281) 218-9332

ir@cyberonics.com


'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cyberonics Provides Business Update Based on Final Ambulatory Payment Classification Rate Change Announcement by CMS
2. Cyberonics Corporate Headquarters Fully Operational Following Hurricane Ike
3. Cyberonics to Present at UBS Global Life Sciences Conference
4. Cyberonics to Present at Canaccord Adams 28th Annual Global Growth Conference
5. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 First Quarter Financial Results
6. Cyberonics to Present at Collins Stewart Fourth Annual Growth Conference
7. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2008 Financial Results
8. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
9. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
10. Cyberonics Licenses Obesity-Related Patents
11. NutraCea Announces Third Quarter 2008 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of Healthcare and ... hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will provide ... and value analysis professionals have a ‘seat at the table’ with clinical committees ...
(Date:3/27/2017)... , ... March 27, 2017 , ... According to the ... cancer, including all stages, is more than 95%. Once the cancer spreads to other ... than 30%. To find out how to avoid this latter group, tune in to ...
(Date:3/27/2017)... ... March 27, 2017 , ... Sodium ... methods are complicated and require expert user knowledge. In a live webinar on ... to the simplified, yet highly accurate, determination of sodium. , It has long ...
(Date:3/27/2017)... ... March 27, 2017 , ... ?Grow Healthy Vending LLC announced ... litigation between itself and 1800 Vending DBA Healthy You Vending. (Civil No. 1:14-CV-00121-CW/ ... to announce that we have now reached a settlement agreement regarding the ongoing ...
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... deaths soared 167%,(1) with opioids alone responsible for over 33,000 of the 52,404 ... has sponsored Assembly Bill (AB) 1512, which proposes a tax on prescription opioids ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... --  Genprex, Inc. , a privately held, clinical-stage biopharmaceutical company developing ... Company,s Chief Operating Officer, is scheduled to present a corporate overview ... Annual Cancer BioPartnering & Investment Forum: Tuesday, March 28, 2017 at ... ... Annual Future Leaders in Biotech Industry – Friday, April 7, 2017 ...
(Date:3/27/2017)... -- Invivotek, LLC, a Genesis Biotechnology Group ® ... contract research organization (CRO), announced the completion of the ... research facility in Hamilton, New Jersey ... source to reduce costs and lessen the CRO facility,s ... Farm follows Invivotek,s recent expansion from a 19,712 square ...
(Date:3/24/2017)... Oregon and PUNE, India , March 24, 2017 /PRNewswire/ ... 2015, and is estimated to reach $2,614 million by 2022, Globally, registering a CAGR ... to generate the highest revenue, and is projected to dominate the market during the ... ... Allied Market Research Logo ...
Breaking Medicine Technology: